Lam, A. H., Holt, E., Ridouani, F., Tuttle, R. M., Tufano, R. P., Park, A. W., Mauri, G., Kuo, J. H., Baek, J. H., Abi-Jaoudeh, N., & Camacho, J. C. (2024). Role of Locoregional Therapies in the Treatment of Thyroid Pathology: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel. Journal of Vascular and Interventional Radiology, 35(12), 1752–1759. https://doi.org/10.1016/j.jvir.2024.08.008

Stillman, M., Kuo, E. J., Liou, R., Almuqate, A., Virk, R., Lee, J. A., Kuo, J. H., & McManus, C. M. (2024). Molecular Testing for Bethesda III Thyroid nodules: Trends in Implementation, Cytopathology Call Rates, Surgery Rates, and Malignancy Yield at a Single Institution. Thyroid®. https://doi.org/10.1089/thy.2023.0664

Shah, M., & McManus, C. (2024). The Role of Radiofrequency Ablation in Benign and Malignant Thyroid Nodules. Surgical Clinics of North America, 104(4), 779–789. https://doi.org/10.1016/j.suc.2024.02.007

McConnell, R. J., Kamysh, O., O’Kane, P. L., Greenebaum, E., Rozhko, A. V., Yauseyenka, V. V., Minenko, V. F., Drozdovitch, V., Yarets, Y., Kukhta, T., Mabuchi, K., Little, M. P., Cahoon, E. K., & Zablotska, L. B. (2024). Radiation Dose Does Not Affect the Predictive Value of Thyroid Biopsy for Diagnosing Papillary Thyroid Cancer in a Belarusian Cohort Exposed to Chernobyl Fallout. Acta Cytologica, 68(1), 34–44. Portico. https://doi.org/10.1159/000536387

Madrigal, J. M., Troisi, R., Surcel, H., Öhman, H., Kivelä, J., Kiviranta, H., Rantakokko, P., Koponen, J., Medgyesi, D. N., Kitahara, C. M., McGlynn, K. A., Sampson, J., Albert, P. S., Ward, M. H., & Jones, R. R. (2023). Prediagnostic serum concentrations of per‐ and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort. International Journal of Cancer, 154(6), 979–991. Portico. https://doi.org/10.1002/ijc.34776

Carlisle, K. M., Brown, J. P., Kim, J., Turner, D. J., Slejko, J. F., Kuo, J. H., Mullins, C. D., & Hu, Y. (2024). Age-stratified comparison of active surveillance versus radiofrequency ablation for papillary thyroid microcarcinoma using decision analysis. Surgery, 175(1), 153–160. https://doi.org/10.1016/j.surg.2023.06.054

Schultz, K. A. P., Chintagumpala, M., Piao, J., Chen, K. S., Gartrell, R., Christison‐Lagay, E., Berry, J. L., Shah, R., & Laetsch, T. W. (2023). Children’s Oncology Group’s 2023 blueprint for research: Rare tumors. Pediatric Blood & Cancer, 70(S6). Portico. https://doi.org/10.1002/pbc.30574

Shabbir, A., Kojadinovic, A., Shafiq, T., & Mundi, P. S. (2023). Targeting RET alterations in cancer: Recent progress and future directions. Critical Reviews in Oncology/Hematology, 181, 103882. https://doi.org/10.1016/j.critrevonc.2022.103882

Ma, E. Z., Kuo, J. H., Malek, R., Turner, D. J., Olson, J. A., Slejko, J. F., Mullins, C. D., & Hu, Y. (2023). Total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves’ disease. Surgery, 173(1), 193–200. https://doi.org/10.1016/j.surg.2022.06.044

Xu, X., Hendryx, M., Liang, X., Kahe, K., Li, Y., & Luo, J. (2022). Dietary selenium intake and thyroid cancer risk in postmenopausal women. Nutrition, 103–104, 111840. https://doi.org/10.1016/j.nut.2022.111840

Tuttle, R. M., Fagin, J., Minkowitz, G., Wong, R., Roman, B., Patel, S., Untch, B., Ganly, I., Shaha, A., Shah, J., Li, D., Bach, A., Girshman, J., Lin, O., Cohen, M., Cohen, J.-M., Cracchiolo, J., Ghossein, R., Sabra, M., … Morris, L. (2022). Active Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns. Thyroid, 32(11), 1337–1345. https://doi.org/10.1089/thy.2022.0325

Wang, Z., Luo, J., Zhang, Y., Xun, P., & Chen, Z. (2022). Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis. PLOS ONE, 17(7), e0271038. https://doi.org/10.1371/journal.pone.0271038

Zhang, W., Ruan, X., Li, Y., Zhi, J., Hu, L., Hou, X., Shi, X., Wang, X., Wang, J., Ma, W., Gu, P., Zheng, X., & Gao, M. (2022). KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway. Theranostics, 12(4), 1500–1517. https://doi.org/10.7150/thno.66142